New WHO recommendations to accelerate progress on TB

WHO issues new guidance to improve treatment of multidrug-resistant TB.

Read More →

ECDC-WHO report: TB surveillance and monitoring in Europe 2019

Every hour 30 people are diagnosed with TB in the European Region. It’s time to make TB a disease of the past.

Read More →

TB CAB statement on safety of using bedaquiline and delamanid together

Global TB CAB welcomes confirmation of safety of using bedaquiline and delamanid together, urges uptake.

Read More →

TAG statement on FDA priority review of pretomanid

Statement from Treatment Action Group on FDA priority peview of TB Alliance’s new anti-TB drug pretomanid.

Read More →

World TB Day 2019: IT'S TIME for action!

The World Health Organization releases advocacy and communications materials to support awareness building and promotion in the lead up to and on World TB Day.

Read More →

IT'S TIME for World TB Day 2019

#WorldTBDay2019 campaign starts now; The Stop TB Partnership releases World TB Day 2019 campaign toolkit.

Read More →

TB in Prisons: a People’s Introduction to the Law

An advocacy tool breaking down legal fundamentals in an accessible and practical way, meant to guide activists through the role of the law in aiding incarcerated populations in the TB response. 

Read More →

TB activists for first time challenge TB drug patent in India

TB activists for first time challenge TB drug patent in India, in bid to prevent Johnson & Johnson from extending monopoly.

Read More →

WHO updates its treatment guidelines for MDR/RR-TB

The updated WHO treatment guidelines recommend that drug-resistant TB be treated with oral drugs only, including newer, more potent drugs with fewer side effects.

Read More →

Advocates call on Indian government to improve its response to drug-resistant TB

Advocates call for minimizing the use of injectable agents and scaling up universal drug susceptibility testing.

Read More →

Page 1 of 96 · Total posts: 10

1 2 Last→